Clinical Trials in Atlanta

Showing 6961-6980 of 19,805 trials

Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule

NCT03329001

This is a three stage, open label, randomized-sequence, single-crossover Phase 1 study to evaluate the relative bioavailability (BA) and Bioequivalence (BE) of niraparib administered as a tablet formulation compared to the reference capsule formulation currently marketed in the United States. Stage 3 evaluates the effect of a high-fat meal on niraparib pharmacokinetics (PK) following a single dose of the tablet. The Extension Phase of this study is to enable participants enrolled in the study to continue to receive treatment with niraparib tablets if they are tolerating it and, in the Investigator's opinion, may receive benefit.

Neoplasms

Tesaro, Inc.236 participantsStarted Dec 2017

Encinitas, California, United States • Fresno, California, United States • Denver, Colorado, United States +13 more locations

RECRUITINGPhase 1/2< 1 mile

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

NCT04879043

This study will assess the safety, tolerability, pharmacokinetics (PK) and the therapeutic potential of HDP-101 in patients with plasma cell disorders including multiple myeloma.

Multiple MyelomaPlasma Cell Disorder

Heidelberg Pharma AG78 participantsStarted Feb 2022

Atlanta, Georgia, United States • New York, New York, United States • Houston, Texas, United States +13 more locations

Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib Capsule

Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma

Find Trials by Condition in Atlanta

Treadmill Training in People With Parkinson's Disease

Study of VIB7734 for the Treatment of Moderate to Severely Active SLE

HOPE in Action Prospective Multicenter, Clinical Trial of Deceased HIVD+ Kidney Transplants for HIV+ Recipients

Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism

Coaching for Advanced Practice Providers

A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer

Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid Cancer

A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function

Adjunct Collection of Additional Biorepository Data From Patients Enrolled in Diabetic Foot Consortium (DFC) Trials

A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Pulmonary Vascular Changes in Early Chronic Obstructive Pulmonary

Metastatic Solid Cancer Clinical Trial

A Study of MK-8189 in Participants With Schizophrenia (MK-8189-014)